• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰头腺癌患者静脉重建的疗效

Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head.

作者信息

Howard Thomas J, Villanustre Nicholas, Moore Seth A, DeWitt John, LeBlanc Julia, Maglinte Dean, McHenry Lee

机构信息

Pancreas Research Group and the Department of Surgery, Indiana University School of Medicine, Indianapolis, Indiana 46202, USA.

出版信息

J Gastrointest Surg. 2003 Dec;7(8):1089-95. doi: 10.1016/j.gassur.2003.07.010.

DOI:10.1016/j.gassur.2003.07.010
PMID:14675720
Abstract

Pancreaticoduodenectomy is often avoided in patients with portal or superior mesenteric venous involvement due to the perception that venous resection is complex, morbid, and carries a poor long-term survival. Our recent experience using state-of-the-art imaging and strict resection criteria show that venous reconstruction increases operative time, transfusion requirements, intensive care unit stay, and total hospital length of stay, but has no significant impact on operative morbidity rates, mortality rates, or the incidence of positive histologic margins. Kalpan-Meier life table analysis shows similar survival curves when compared to a contemporary cohort of patients who do not undergo venous reconstruction.

摘要

由于认为静脉切除复杂、病态且长期生存率低,门静脉或肠系膜上静脉受累的患者通常避免行胰十二指肠切除术。我们最近使用先进成像技术和严格切除标准的经验表明,静脉重建会增加手术时间、输血需求、重症监护病房停留时间和总住院时间,但对手术发病率、死亡率或组织学切缘阳性发生率没有显著影响。Kaplan-Meier生存表分析显示,与同期未进行静脉重建的患者队列相比,生存曲线相似。

相似文献

1
Efficacy of venous reconstruction in patients with adenocarcinoma of the pancreatic head.胰头腺癌患者静脉重建的疗效
J Gastrointest Surg. 2003 Dec;7(8):1089-95. doi: 10.1016/j.gassur.2003.07.010.
2
Postoperative morbidity and long-term survival after pancreaticoduodenectomy with superior mesenterico-portal vein resection.肠系膜上静脉-门静脉切除的胰十二指肠切除术后的术后发病率和长期生存率。
J Gastrointest Surg. 2006 Sep-Oct;10(8):1106-15. doi: 10.1016/j.gassur.2006.04.002.
3
Vascular reconstruction plays an important role in the treatment of pancreatic adenocarcinoma.血管重建在胰腺癌治疗中发挥着重要作用。
J Vasc Surg. 2015 Feb;61(2):475-80. doi: 10.1016/j.jvs.2014.09.003. Epub 2014 Oct 29.
4
Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline resectability.伴有可切除性临界状态的胰腺癌行胰十二指肠切除术并血管重建术。
World J Gastroenterol. 2014 Dec 14;20(46):17448-55. doi: 10.3748/wjg.v20.i46.17448.
5
Rationale for en bloc vein resection in the treatment of pancreatic adenocarcinoma adherent to the superior mesenteric-portal vein confluence. Pancreatic Tumor Study Group.整块切除静脉在治疗粘连于肠系膜上静脉-门静脉汇合处的胰腺腺癌中的理论依据。胰腺肿瘤研究小组。
Ann Surg. 1996 Feb;223(2):154-62. doi: 10.1097/00000658-199602000-00007.
6
Safety and efficacy of cryopreserved homologous veins for venous reconstruction in pancreatoduodenectomy.冷冻保存的同种异体静脉在胰十二指肠切除术中用于静脉重建的安全性和有效性。
Surgery. 2017 Feb;161(2):385-393. doi: 10.1016/j.surg.2016.08.016. Epub 2016 Oct 7.
7
Long-term outcomes following en bloc resection for pancreatic ductal adenocarcinoma of the head with portomesenteric venous invasion.胰头导管腺癌伴门静脉肠系膜静脉侵犯整块切除术的长期结果。
Asian J Surg. 2021 Jan;44(1):313-320. doi: 10.1016/j.asjsur.2020.07.021. Epub 2020 Sep 21.
8
Postoperative Outcomes of Tangential Segmental Resection and End-to-end Reconstruction of the Superior Mesenterico-Portal Vein During Pancreatoduodenectomy for Pancreatic Adenocarcinoma: A Single-Center Experience.胰头十二指肠切除术治疗胰腺腺癌时肠系膜上-门静脉端侧节段切除与端端重建的术后结果:单中心经验。
Anticancer Res. 2021 Oct;41(10):5123-5130. doi: 10.21873/anticanres.15329.
9
[Cephalic pancreaticoduodenectomy with mesentericoportal venous reconstruction. Technical features].[伴有肠系膜门静脉重建的胰十二指肠切除术。技术特点]
Cir Esp. 2006 Aug;80(2):105-8. doi: 10.1016/s0009-739x(06)70932-0.
10
Portal mesenteric shunting for reconstruction of the visceral venous system.门静脉肠系膜分流术用于重建内脏静脉系统。
J Am Coll Surg. 2000 Oct;191(4):469-73. doi: 10.1016/s1072-7515(00)00687-6.

引用本文的文献

1
Curative intent treatment for pancreatic duct adenocarcinoma invade superior mesenteric vein.针对侵犯肠系膜上静脉的胰腺导管腺癌的根治性治疗。
Radiol Case Rep. 2024 Sep 24;19(12):6265-6268. doi: 10.1016/j.radcr.2024.09.033. eCollection 2024 Dec.
2
The impact of venous resection in pancreatoduodectomy: A systematic review and meta-analysis.胰十二指肠切除术时静脉切除的影响:系统评价和荟萃分析。
Medicine (Baltimore). 2021 Oct 8;100(40):e27438. doi: 10.1097/MD.0000000000027438.
3
The Impact on Survival and Morbidity of Portal-Mesenteric Resection During Pancreaticoduodenectomy for Pancreatic Head Adenocarcinoma: A Systematic Review and Meta-Analysis of Comparative Studies.

本文引用的文献

1
Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis.基于证据的胰腺癌和慢性胰腺炎胰头切除术
Ann Surg. 2002 Aug;236(2):137-48. doi: 10.1097/00000658-200208000-00001.
2
Is pancreaticoduodenectomy with mesentericoportal venous resection safe and worthwhile?胰十二指肠切除术联合肠系膜门静脉切除是否安全且值得?
Am J Surg. 2001 Aug;182(2):120-9. doi: 10.1016/s0002-9610(01)00686-9.
3
The role of extended radical operation for pancreatic cancer.扩大根治性手术在胰腺癌治疗中的作用。
胰头腺癌胰十二指肠切除术中门静脉-肠系膜上静脉切除对生存和发病率的影响:比较研究的系统评价和荟萃分析
Cancers (Basel). 2020 Jul 20;12(7):1976. doi: 10.3390/cancers12071976.
4
Venous resection during pancreatectomy for pancreatic cancer: a systematic review.胰腺癌胰十二指肠切除术中的静脉切除:一项系统评价
Transl Gastroenterol Hepatol. 2019 Jun 19;4:46. doi: 10.21037/tgh.2019.06.01. eCollection 2019.
5
The value of combined vein resection in pancreaticoduodenectomy for pancreatic head carcinoma: a meta-analysis.胰头癌胰十二指肠切除术中联合静脉切除的价值:一项荟萃分析。
BMC Surg. 2019 Jul 8;19(1):84. doi: 10.1186/s12893-019-0540-6.
6
Pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head with venous resection.胰十二指肠切除术治疗伴静脉切除的胰头导管腺癌。
Radiol Oncol. 2016 Jul 19;50(3):321-8. doi: 10.1515/raon-2015-0017. eCollection 2016 Sep 1.
7
Improving outcomes in pancreatic cancer: key points in perioperative management.改善胰腺癌治疗效果:围手术期管理要点
World J Gastroenterol. 2014 Oct 21;20(39):14237-45. doi: 10.3748/wjg.v20.i39.14237.
8
Patency rates of portal vein/superior mesenteric vein reconstruction after pancreatectomy for pancreatic cancer.胰腺癌胰十二指肠切除术后门静脉/肠系膜上静脉重建的通畅率
J Gastrointest Surg. 2014 Nov;18(11):2016-25. doi: 10.1007/s11605-014-2635-9. Epub 2014 Sep 17.
9
Peripancreatic soft tissue involvement: independent outcome predictor in patients with resected pancreatic adenocarcinoma.胰周软组织受累:切除的胰腺腺癌患者的独立预后预测因素
Int Surg. 2014 Jan-Feb;99(1):62-70. doi: 10.9738/INTSURG-D-13-00112.1.
10
Vascular resection in pancreatic adenocarcinoma with portal or superior mesenteric vein invasion.胰腺腺癌伴门静脉或肠系膜上静脉侵犯的血管切除术。
World J Gastroenterol. 2013 Dec 14;19(46):8740-4. doi: 10.3748/wjg.v19.i46.8740.
Hepatogastroenterology. 2001 Jul-Aug;48(40):949-52.
4
Segmental resection and wedge excision of the portal or superior mesenteric vein during pancreatoduodenectomy.胰十二指肠切除术中门静脉或肠系膜上静脉的节段性切除和楔形切除。
Surgery. 2001 Feb;129(2):158-63. doi: 10.1067/msy.2001.110221.
5
Pancreaticoduodenectomy with or without extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma: comparison of morbidity and mortality and short-term outcome.胰十二指肠切除术联合或不联合扩大腹膜后淋巴结清扫术治疗壶腹周围腺癌:发病率、死亡率及短期疗效比较
Ann Surg. 1999 May;229(5):613-22; discussion 622-4. doi: 10.1097/00000658-199905000-00003.
6
Standard versus extended lymphadenectomy associated with pancreatoduodenectomy in the surgical treatment of adenocarcinoma of the head of the pancreas: a multicenter, prospective, randomized study. Lymphadenectomy Study Group.标准与扩大淋巴结清扫术联合胰十二指肠切除术治疗胰头腺癌的多中心、前瞻性、随机研究。淋巴结清扫术研究组
Ann Surg. 1998 Oct;228(4):508-17. doi: 10.1097/00000658-199810000-00007.
7
Extended radical pancreatectomy for carcinoma of the head of the pancreas.胰头癌的扩大根治性胰腺切除术
Hepatogastroenterology. 1998 May-Jun;45(21):849-54.
8
Survival following pancreaticoduodenectomy with resection of the superior mesenteric-portal vein confluence for adenocarcinoma of the pancreatic head.胰十二指肠切除术联合切除肠系膜上静脉-门静脉汇合部治疗胰头腺癌后的生存情况。
Br J Surg. 1998 May;85(5):611-7. doi: 10.1046/j.1365-2168.1998.00641.x.
9
Portal vein involvement in pancreatic cancer: a sign of unresectability?门静脉受累在胰腺癌中:是不可切除的标志吗?
Adv Surg. 1997;31:375-94.
10
Carcinoma of the periampullary region: who benefits from portal vein resection?壶腹周围癌:谁能从门静脉切除术中获益?
Am J Surg. 1996 Jan;171(1):170-4; discussion 174-5. doi: 10.1016/S0002-9610(99)80094-4.